Fortis Group Advisors, LLC
- SEC CIK
- 0001815183
- Latest filing
- Jul 24, 2026
LXRX holding history
Lexicon Pharmaceuticals, Inc. in every 13F filed by Fortis Group Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 50,000
- Value
- $120.0K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 50,000 | $120.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 50,000 | $80.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 50,000 | $58.0K | <0.1% | −7,800−13.5% | Reduced | Holders |
| Q3 2025 | 57,800 | $79.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 57,800 | $61.8K | <0.1% | +20,000+52.9% | Added | Holders |
| Q1 2025 | 37,800 | $17.4K | <0.1% | +37,800 | New | Holders |